
No. of Pages: 148 | Report Code: TIPRE00021090 | Category: Life Sciences
No. of Pages: 148 | Report Code: TIPRE00021090 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentationss
1.3.1 Antacid Market – By Dosage Form
1.3.2 Antacid Market – By Drug Class
1.3.3 Antacid Market – By Distribution Channel
1.3.4 Europe Antacid Market – By Country
2. Europe Antacid Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antacid Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antacid Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Gastrointestinal Diseases
5.1.2 Higher Incidence of Ageing Population
5.2 Market Restraints
5.2.1 Lack of Knowledge Associated with Gastrointestinal Diseases
5.3 Market Opportunities
5.3.1 Increasing Research and Development Activities Regarding Gastric Disorders
5.4 Future Trends
5.4.1 Increasing Growth of the Pharmaceutical Industry
5.5 Impact Analysis
6. Antacid Market – Europe Analysis
6.1 Europe Antacid Market Revenue Forecasts and Analysis
7. Europe Antacid Market Analysis and Forecasts to 2027 – By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8. Europe Antacid Market Analysis and Forecasts to 2027– By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.4 H Antagonist
8.4.1 Overview
8.4.2 H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Antacid Market Analysis and Forecasts to 2027– By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis
10.1 Europe: Antacid Market
10.1.1 Overview
10.1.2 Europe: Antacid Market, by Country, 2019 & 2027 (%)
10.1.3 Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Germany: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.3.3 Germany: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.3.3.1 Germany: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.3.4 Germany: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.4 UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UK: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.4.3 UK: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.4.3.1 UK: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.4.4 UK: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.5 France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 France: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.5.3 France: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.5.3.1 France: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.5.4 France: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.6 Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Spain: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.6.3 Spain: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.6.3.1 Spain: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.6.4 Spain: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.7 Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Italy: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.7.3 Italy: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.7.3.1 Italy: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.7.4 Italy: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.8 Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.8.3 Rest of Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.8.3.1 Rest of Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.8.4 Rest of Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Europe Antacid Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. COMPANY PROFILES
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 2. Germany Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 3. Germany Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 4. Germany Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. UK Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 6. UK Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 7. UK Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 8. UK Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. France Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 10. France Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. France Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 12. France Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Spain Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 14. Spain Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. Spain Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 16. Spain Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 18. Italy Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 23. Rest of Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. Rest of Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms, Antacid Market
LIST OF FIGURES
Figure 1. Antacid Market Segmentation
Figure 2. Europe Antacid Market Overview
Figure 3. Tablet Segment Held Largest Share of Dosage Form in Antacid Market
Figure 4. Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Antacid Market - Europe PEST Analysis
Figure 7. Antacid Market Impact Analysis of Driver and Restraints
Figure 8. Europe Antacid Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 10. Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 14. Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 21. Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Europe: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Europe: Antacid Market, by Country, 2019 & 2027 (%)
Figure 26. Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in European Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)